Article
Pneumocystis Cytochrome b Mutants Associated With Atovaquone Prophylaxis Failure as the Cause of Pneumocystis Infection Outbreak Among Heart Transplant Recipients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 31 Aug 2018
Argy Nicolas, Le Gal Solène, Coppée Romain, Song Zehua, Vindrios William, Massias Laurent, Kao Wei-Chun, Hunte Carola, Yazdanpanah Yazdan, Lucet Jean-Christophe, Houzé Sandrine, Clain Jérôme, Nevez Gilles
Abstract excerpt
Background: Although trimethoprim-sulfamethoxazole is the more efficient drug for prophylactic and curative treatment of pneumocystosis, atovaquone is considered a second-line prophylactic treatment in immunocompromised patients. Variations in atovaquone absorption and mutant fungi selection after atovaquone exposure have been associated with atovaquone prophylactic failure. We report here a Pneumocystis...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
